Baxter International BAX Rest of world — Net Sales
Discontinued — last reported Q4 '25
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Baxter International’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's rest of world — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's rest of world — net sales?
- Baxter International (BAX) reported rest of world — net sales of $1.02B in Q4 2025.
- How has Baxter International's rest of world — net sales changed year-over-year?
- Baxter International's rest of world — net sales increased by 14.5% year-over-year, from $894M to $1.02B.
- What is the long-term trend for Baxter International's rest of world — net sales?
- Over 3 years (2021 to 2025), Baxter International's rest of world — net sales has grown at a -3.9% compound annual growth rate (CAGR), from $4.2B to $3.73B.
- What does rest of world — net sales mean?
- Total revenue generated from the company's operations in international markets outside of its primary domestic region.
- How do you interpret rest of world — net sales?
- An increase suggests successful market penetration or growing demand for medical products in international territories, while a decrease may signal competitive pressure, regulatory hurdles, or unfavorable macroeconomic conditions in those regions.
- How does rest of world — net sales compare across companies?
- Comparable to 'International Revenue' or 'Revenue by Geography' reported by other multinational medical device and healthcare equipment manufacturers.